Laboratorios Sanfer’s Acquisition of a Controlling Stake in Laboratorios Pasteur


CMS Carey & Allende and Barros & Errázuriz advised on the transaction

Mexican pharmaceutical group Laboratorios Sanfer – through its subsidiary Invekra – executed the acquisition of a controlling stake in Laboratorios Pasteur.

The deal’s value is confidential.

Sanfer is backed by Canadian pension fund Caisse de dépôt et placement du Québec, which invested USD 500M in the Mexican company in return for a 24% stake last year. The investment was part of the fund’s strategy to expand its holdings in Latin America. The deal represents one of Mexico’s largest-ever minority private capital transactions.

Sanfer researches, produces and supplies medicine in Mexico and has a presence in ten Latin American countries including Argentina, Chile and Peru. Chilean counterpart, Pasteur, is among the largest medical groups in Chile and its operations are based in the region of Bíobío, southern Chile.

CMS Carey & Allende advised Invekra with Jorge Allende Destuet (Picture), Ignacio Errazquin and Sofía Haupt.

Barros & Errázuriz advised Laboratorio Pasteur S.A. with Luis Alberto Letelier Herrera, Juan Cristóbal Schmidt Canessa and Andrés Vaccaro Carrasco.

Involved fees earner: Luis Alberto Letelier Herrera – Barros & Errázuriz Abogados; Juan Cristóbal Schmidt Canessa – Barros & Errázuriz Abogados; Andrés Vaccaro – Barros & Errázuriz Abogados; Jorge Allende D. – CMS Carey & Allende; Ignacio Errazquin – CMS Carey & Allende; Sofía Haupt – CMS Carey & Allende;

Law Firms: Barros & Errázuriz Abogados; CMS Carey & Allende;

Clients: Invekra S.A.P.I. de C.V. ; Laboratorio Pasteur S.A.; Laboratorios Sanfer S.A. de C.V.;

Author: Ambrogio Visconti.